rs11651
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_212482.4(FN1):āc.7161T>Cā(p.Tyr2387=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.321 in 1,573,182 control chromosomes in the GnomAD database, including 85,237 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.26 ( 6170 hom., cov: 31)
Exomes š: 0.33 ( 79067 hom. )
Consequence
FN1
NM_212482.4 synonymous
NM_212482.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.46
Genes affected
FN1 (HGNC:3778): (fibronectin 1) This gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. The encoded preproprotein is proteolytically processed to generate the mature protein. Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis. The gene has three regions subject to alternative splicing, with the potential to produce 20 different transcript variants, at least one of which encodes an isoform that undergoes proteolytic processing. The full-length nature of some variants has not been determined. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-215364969-A-G is Benign according to our data. Variant chr2-215364969-A-G is described in ClinVar as [Benign]. Clinvar id is 1169959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-215364969-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.46 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.47 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FN1 | NM_212482.4 | c.7161T>C | p.Tyr2387= | synonymous_variant | 44/46 | ENST00000354785.11 | NP_997647.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FN1 | ENST00000354785.11 | c.7161T>C | p.Tyr2387= | synonymous_variant | 44/46 | 1 | NM_212482.4 | ENSP00000346839 | P1 |
Frequencies
GnomAD3 genomes AF: 0.262 AC: 39727AN: 151892Hom.: 6160 Cov.: 31
GnomAD3 genomes
AF:
AC:
39727
AN:
151892
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.322 AC: 63322AN: 196418Hom.: 11035 AF XY: 0.335 AC XY: 34885AN XY: 104080
GnomAD3 exomes
AF:
AC:
63322
AN:
196418
Hom.:
AF XY:
AC XY:
34885
AN XY:
104080
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.327 AC: 465312AN: 1421172Hom.: 79067 Cov.: 31 AF XY: 0.333 AC XY: 234233AN XY: 703216
GnomAD4 exome
AF:
AC:
465312
AN:
1421172
Hom.:
Cov.:
31
AF XY:
AC XY:
234233
AN XY:
703216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.262 AC: 39757AN: 152010Hom.: 6170 Cov.: 31 AF XY: 0.262 AC XY: 19453AN XY: 74290
GnomAD4 genome
AF:
AC:
39757
AN:
152010
Hom.:
Cov.:
31
AF XY:
AC XY:
19453
AN XY:
74290
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1391
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Glomerulopathy with fibronectin deposits 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Spondylometaphyseal dysplasia - Sutcliffe type Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at